From Jeff Brown, editor, Exponential Tech Investor: “Quantifying” ourselves has become a movement. Starting slowly and quietly in the latter part of the last decade, the trend of people acquiring data on all aspects of their lives—with Fitbits and Apple Watches and other kinds of “wearables”—is now everywhere.

The purpose is to quantify oneself. And in so doing, people can take a data-driven approach to improving their lives.

The market for fitness-related wearables will easily top $1 billion this year. You may be familiar with popular brands such as Fitbit (FIT) or Jawbone (private). Their products can do things like continuously take your heart rate, track workouts and calories burned, monitor the quality of your sleep, and even set alarms.

This is just the beginning, however. I am tracking two private companies that are advancing wearables to the next generation of functionality.

Vital Connect has developed a series of biosensors that can be used for cardiac monitoring, clinical trials, and post-discharge monitoring.

Chart
Vital Connect’s home monitoring patch.

Quanttus is focused on clinical-grade vital-sign monitoring of things like sleep, dehydration, blood pressure, diabetes, and inactivity.

Even Alphabet (GOOG) is working on advanced wearable technology. Two years ago, it announced that it was developing a “smart” contact lens. This wearable for your eye contains a tiny wireless chip and a glucose sensor that has the ability to transmit blood sugar levels to a smartphone.

Recommended Link

[URGENT] Will You Still Buy Gold After Watching This 63-Second Clip?
There’s an URGENT new theory on gold that you have to see… It’s so urgent, in fact, Jim Rickards dropped everything to record a short 63-second video clip. After you see what he says, you may question everything you know about gold. Including the recent price action… Will You Still Buy Gold After Watching THIS?
—

These wearable technologies will be part of a massive revolution in health care that will improve the quality of health information and diagnostics. They’ll also lower costs exponentially.

Most importantly, though, these technologies will save countless lives by providing early diagnosis of potentially life-threatening conditions.

Reeves’ Note: Jeff’s spent the past three decades uncovering the latest tech trends and how to profit from them. He’s given his subscribers the opportunity to book gains of 38%, 143%, and 175%—in just the last few months…

Recently, Jeff identified a startup that works with what MIT Technology Review calls “the biggest biotech discovery of the century.” His sources are pointing to TODAY as the day this company could go public. You can learn how to get in on the opportunity right here.